🇺🇸 FDA
Patent

US 8815830

Nucleosides with antiviral and anticancer activity

granted A61PA61P1/16A61P31/12

Quick answer

US patent 8815830 (Nucleosides with antiviral and anticancer activity) held by Regents of the University of Minnesota expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P1/16, A61P31/12, A61P31/14, A61P35/00